The prevalence of cardiac valvular insufficiency assessed by transthoracic echocardiography in obese patients treated with appetite-suppressant drugs.

PubWeight™: 1.51‹?› | Rank: Top 4%

🔗 View Article (PMID 9731086)

Published in N Engl J Med on September 10, 1998

Authors

M A Khan1, C A Herzog, J V St Peter, G G Hartley, R Madlon-Kay, C D Dick, R W Asinger, J T Vessey

Author Affiliations

1: Department of Medicine, Hennepin County Medical Center, Health System Minnesota, Minneapolis 55415, USA.

Articles citing this

Carcinoid heart disease: presentation, diagnosis, and management. Heart (2004) 1.65

Antibiotic susceptibility of Tropheryma whipplei in MRC5 cells. Antimicrob Agents Chemother (2004) 1.14

Worldwide perspective of valve disease. Heart (2000) 1.01

Comparison of monoamine and corticosterone levels 24 h following (+)methamphetamine, (+/-)3,4-methylenedioxymethamphetamine, cocaine, (+)fenfluramine or (+/-)methylphenidate administration in the neonatal rat. J Neurochem (2006) 1.00

Serotonin receptors and heart valve disease--it was meant 2B. Pharmacol Ther (2011) 0.99

Appetite suppressants and valvular heart disease - a systematic review. BMC Clin Pharmacol (2002) 0.98

Benfluorex and unexplained valvular heart disease: a case-control study. PLoS One (2010) 0.97

Valvular regurgitation and surgery associated with fenfluramine use: an analysis of 5743 individuals. BMC Med (2008) 0.87

Role of serotoninergic pathways in drug-induced valvular heart disease and diagnostic features by echocardiography. J Am Soc Echocardiogr (2009) 0.85

Weight loss is still an essential intervention in obesity and its complications: a review. J Obes (2012) 0.80

Appetite suppressants and valvular heart disease. N Engl J Med (1998) 0.78

Cardiotoxic effects of fenfluramine hydrochloride on isolated cardiac preparations and ventricular myocytes of guinea-pigs. Br J Pharmacol (2000) 0.77

Risk of valvular heart disease associated with use of fenfluramine. BMC Cardiovasc Disord (2003) 0.77

Cardiovascular effects of noncardiovascular drugs. Circulation (2009) 0.76

Valvular heart disease with the use of fenfluramine-phentermine. Tex Heart Inst J (2011) 0.75

Drug-Induced- or Rheumatic- Valvular Heart Disease in Patients Exposed to Benfluorex? PLoS One (2016) 0.75

Cutaneous manifestations of infectious diseases: approach to the patient with fever and rash. Trans Am Clin Climatol Assoc (2001) 0.75

Articles by these authors

Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. N Engl J Med (2001) 5.67

ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation): developed in Collaboration With the North American Society of Pacing and Electrophysiology. J Am Coll Cardiol (2001) 3.65

Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation Investigators. J Am Coll Cardiol (2000) 3.36

ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology. Eur Heart J (2001) 3.34

ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology. Circulation (2001) 3.13

Incidence of left-ventricular thrombosis after acute transmural myocardial infarction. Serial evaluation by two-dimensional echocardiography. N Engl J Med (1981) 3.00

Left atrial diameter in nonvalvular atrial fibrillation: An echocardiographic study. Stroke Prevention in Atrial Fibrillation Investigators. Am Heart J (1999) 2.68

Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation. Stroke Prevention in Atrial Fibrillation III Investigators. J Am Coll Cardiol (1998) 1.95

Using significance tests to evaluate equivalence between two experimental groups. Psychol Bull (1993) 1.89

Cardiac troponin I, cardiac troponin T, and creatine kinase MB in dialysis patients without ischemic heart disease: evidence of cardiac troponin T expression in skeletal muscle. Clin Chem (1997) 1.79

Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials. The Stroke Prevention in Atrial Fibrillation (SPAF) Investigators. Stroke (1999) 1.74

The relationship between health-related quality of life and weight loss. Obes Res (2001) 1.68

Observations on detecting left ventricular thrombus with two dimensional echocardiography: emphasis on avoidance of false positive diagnoses. Am J Cardiol (1981) 1.60

Monoclonal nicotine-specific antibodies reduce nicotine distribution to brain in rats: dose- and affinity-response relationships. Drug Metab Dispos (2005) 1.47

Embolic potential of left ventricular thrombi detected by two-dimensional echocardiography. Circulation (1984) 1.44

Two-dimensional echocardiographic imaging of left ventricular mural vegetations. Am Heart J (1988) 1.42

Patterns of mental health service utilization. Arch Gen Psychiatry (1996) 1.27

Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: I. Reduced flow velocity in the left atrial appendage (The Stroke Prevention in Atrial Fibrillation [SPAF-III] study). J Am Soc Echocardiogr (1999) 1.22

Suppression of ventricular ectopic depolarizations by flecainide acetate, a new antiarrhythmic agent. Circulation (1982) 1.20

A comparison of coronary angioplasty and coronary artery bypass grafting outcomes in chronic dialysis patients. Am J Kidney Dis (1995) 1.14

Diabetes disease stage predicts weight loss outcomes with long-term appetite suppressants. Obes Res (2000) 1.13

Acute necrotising eosinophilic myocarditis. Br Heart J (1984) 1.03

Two-dimensional echocardiographic identification of left ventricular pseudoaneurysm. Am Heart J (1986) 1.01

Two-dimensional echocardiographic demonstration of left atrial thrombi in patients with prosthetic mitral valves. Circulation (1979) 1.00

Indications for echocardiography in patients with ischemic stroke. Neurology (1982) 0.99

Echocardiography in the evaluation of cardiac sources of emboli: the role of transthoracic echocardiography. Echocardiography (1993) 0.97

Mitral regurgitation associated with reduced thromboembolic events in high-risk patients with nonrheumatic atrial fibrillation. Stroke Prevention in Atrial Fibrillation Investigators. Am J Cardiol (1993) 0.97

Regional stasis of blood in the dysfunctional left ventricle: echocardiographic detection and differentiation from early thrombosis. Circulation (1982) 0.97

Predicting psychiatric emergency admissions and hospital outcome. Med Care (1997) 0.96

Reactive oxygen species may cause myocardial reperfusion injury. Biochem Biophys Res Commun (1985) 0.95

Reversible myocardial contraction abnormalities in patients with an acute noncardiac illness. Chest (1998) 0.95

Two-dimensional echocardiographic identification of complicated aortic root endocarditis: implications for surgery. J Am Coll Cardiol (1987) 0.95

Nurses' attitudes concerning the delivery of brief cessation advice to hospitalized smokers. Prev Med (2001) 0.94

Echocardiography in diagnostic assessment of stroke. Ann Intern Med (1981) 0.92

Frequency of hypokalemia after successfully resuscitated out-of-hospital cardiac arrest compared with that in transmural acute myocardial infarction. Am J Cardiol (1987) 0.91

Aortic plaque in atrial fibrillation: prevalence, predictors, and thromboembolic implications. Stroke (1999) 0.89

Accuracy of technicians versus pharmacists in checking syringes prepared for a dialysis program. Am J Health Syst Pharm (1997) 0.89

Bronchiolitis and rheumatoid arthritis. Am Rev Respir Dis (1981) 0.89

Alcohol-induced congestive cardiomyopathy: an animal model. Cardiovasc Res (1983) 0.88

Two-dimensional echocardiographic imaging of left atrial appendage thrombi. J Am Coll Cardiol (1984) 0.88

Association of varicella, myocarditis, and congestive cardiomyopathy. Pediatr Cardiol (1982) 0.86

Tissue acoustic properties of fresh left ventricular thrombi and visualization by two dimensional echocardiography: experimental observations. Am J Cardiol (1982) 0.84

Condom safety and HIV. Sex Transm Dis (1994) 0.84

Dobutamine stress echocardiography for the detection of significant coronary artery disease in renal transplant candidates. Am J Kidney Dis (1999) 0.84

Pirbuterol: a new oral sympathomimetic amine for the treatment of congestive heart failure. Am Heart J (1981) 0.83

Left ventricular function during spontaneous angina pectoris: effect of sublingual nitroglycerin. Am J Cardiol (1980) 0.81

Effects of nonselective and selective alpha 1-adrenergic blockade on coronary blood flow during exercise. Circ Res (1987) 0.81

Body fluid spaces and blood pressure in hemodialysis patients during amelioration of anemia with erythropoietin. Am J Kidney Dis (1990) 0.80

Comparison of anticoagulant effects and safety of argatroban and heparin in healthy subjects. Pharmacotherapy (2000) 0.80

Femoral endarteritis due to Staphylococcus aureus complicating percutaneous transluminal coronary angioplasty. Am J Med (1989) 0.80

Mesothelioma of the AV node: potential utility of pacing. Pacing Clin Electrophysiol (1988) 0.80

Functional consequences of interventricular septal involvement in right ventricular infarction: echocardiographic, clinical, and hemodynamic observations. Am Heart J (1983) 0.79

Effect of renal function on risedronate pharmacokinetics after a single oral dose. Br J Clin Pharmacol (2000) 0.79

Fatal cardiac arrest during continuous ambulatory monitoring. N Engl J Med (1981) 0.79

Propranolol antagonism of phenylpropanolamine-induced hypertension. Clin Pharmacol Ther (1985) 0.79

Poor long-term survival of dialysis patients after acute myocardial infarction: bad treatment or bad disease? Am J Kidney Dis (2000) 0.78

Troponin I levels and postoperative myocardial infarction following renal transplantation. Am J Nephrol (2012) 0.78

Early peak of creatine kinase-MB in acute myocardial infarction with a nondiagnostic electrocardiogram. Am Heart J (1988) 0.77

Redistribution and enhanced urinary excretion of 2,2',4,4',5,5'-hexachlorobiphenyl (HCB) in rats using HCB-specific IgG and Fab fragments. Biochem Pharmacol (1994) 0.77

Effects of specific antibody Fab fragments on desipramine pharmacokinetics in the rat in vivo and in the isolated, perfused liver. J Pharmacol Exp Ther (1995) 0.76

Factors associated with the risk of liver enzyme elevation in patients with type 2 diabetes treated with a thiazolidinedione. Pharmacotherapy (2001) 0.76

Clinical outcomes of PTCA in chronic renal failure: a case-control study for comorbid features and evaluation of dialysis dependence. J Invasive Cardiol (2001) 0.76

Frequent occurrence of occult pulmonary embolism from venous sheaths during endomyocardial biopsy. J Am Coll Cardiol (1992) 0.76

Effect of beta-adrenergic blockade with timolol on myocardial blood flow during exercise after myocardial infarction in the dog. J Am Coll Cardiol (1984) 0.75

The fen-phen controversy: is regression another piece of the puzzle? Mayo Clin Proc (1999) 0.75

Coronary blood flow during exercise following nonselective and selective alpha 1-adrenergic blockade with indoramin. J Cardiovasc Pharmacol (1986) 0.75

A new stress for stress tests. N Engl J Med (1994) 0.75

Left ventricular thromboembolic occlusion of the popliteal artery treated nonoperatively with local urokinase infusion--a case report. Angiology (1988) 0.75

Atypical systolic clicks produced by prolapsing mitral valve masses. Am J Cardiol (1992) 0.75

Efficacy, safety, hemodynamic effects, and pharmacokinetics of high-dose moricizine during short- and long-term therapy. Clin Pharmacol Ther (1987) 0.75

Two-dimensional echocardiographic characteristics of pericardial hematoma secondary to left ventricular free wall rupture complicating acute myocardial infarction. Am J Cardiol (1991) 0.75

Assessment of doxylamine influence on mixed function oxidase activity upon multiple dose oral administration to normal volunteers. J Pharm Sci (1996) 0.75

Contrast echocardiographic detection of a right-to-left shunting patent ductus arteriosus. J Am Soc Echocardiogr (1990) 0.75

Disposition of antipyrine and acetaminophen given alone and in combination to human subjects. Pharm Res (1990) 0.75

Cardiac biomarkers in the new millennium. Semin Dial (2001) 0.75

Isolated right atrial tamponade after open heart surgery: role of echocardiography in diagnosis and management. Cardiology (1995) 0.75

Dual atrioventricular conduction during an acute inferior myocardial infarction. Electrocardiographic evidence. Chest (1977) 0.75

Two-dimensional echocardiographic detection of left ventricular posterior wall motion abnormalities using an inferior angulation view. Am J Cardiol (1986) 0.75

Reactive hyperemia for the clinical diagnosis of subclavian steal syndrome: report of a case. Stroke (1981) 0.75

Is the aggressive management of hyperlipidemia in nephrotic syndrome mandatory? Kidney Int Suppl (1992) 0.75

Detection of right pulmonary artery thrombosis by two-dimensional echocardiography. Chest (1988) 0.75

Confusion in interpreting pacemaker related rhythms. Pacing Clin Electrophysiol (1989) 0.75

Safety assessment of OTC drugs: doxylamine succinate. Arch Toxicol Suppl (1995) 0.75

Nitroglycerin loss from intravenous solutions administrated with a volumetric infusion pump. Am J Hosp Pharm (1982) 0.75

Abnormal systolic sound associated with mobile prosthetic mitral valve vegetation. Am Heart J (1984) 0.75

Left ventricular diastolic properties and filling characteristics during spontaneous angina pectoris at rest. Am J Cardiol (1983) 0.75

Increasing precordial QRS voltage correlates with improvement in left ventricular function following anterior myocardial infarction. J Electrocardiol (1988) 0.75

The optimal method of coronary revascularization in dialysis patients: choosing between a rock and a hard place. Int J Artif Organs (2000) 0.75

Role of echocardiography in emergencies. Minn Med (1980) 0.75

Two-dimensional echocardiographic detection of right-sided cardiac intracavitary thromboembolus with pulmonary embolism. J Am Coll Cardiol (1984) 0.75

Left atrial myxoma presenting as shock--diagnosis by echocardiography. Minn Med (1979) 0.75

Consideration of clinical variables for choosing new anticoagulant alternatives to warfarin for the management of non-valvular atrial fibrillation. J Clin Pharm Ther (2014) 0.75